Activist 13D/13G Filings - ARCH Venture Fund VII L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
5:11 pm
Purchase		13G908 DEVICES INC
MASS		ARCH Venture Fund VII L.P.5,782,548
16.600%		26,106increase
(+0.45%)		View
2024-02-09
5:34 pm
Purchase		13G908 DEVICES INC
MASS		ARCH Venture Fund VII L.P.5,756,442
17.800%		11,843increase
(+0.21%)		View
2023-02-13
4:06 pm
Purchase		13G908 DEVICES INC
MASS		ARCH Venture Fund VII L.P.5,744,599
18.100%		12,313increase
(+0.21%)		View
2022-02-11
4:55 pm
Purchase		13GUnity Biotechnology Inc.
UBX		ARCH Venture Fund VII L.P.10,138,859
17.500%		38,560increase
(+0.38%)		View
2022-02-08
3:03 pm
Purchase		13G908 DEVICES INC
MASS		ARCH Venture Fund VII L.P.5,732,286
18.500%		6,440increase
(+0.11%)		View
2021-02-04
2:03 pm
Purchase		13G908 DEVICES INC
MASS		ARCH Venture Fund VII L.P.5,725,846
21.100%		5,725,846increase
(New Position)		View
2021-02-02
5:03 pm
Purchase		13GUnity Biotechnology Inc.
UBX		ARCH Venture Fund VII L.P.10,100,299
19.100%		38,559increase
(+0.38%)		View
2021-02-02
5:02 pm
Sale		13GTwist Bioscience Corp
TWST		ARCH Venture Fund VII L.P.0
0.000%		-3,367,158decrease
(Position Closed)		View
2021-02-02
5:02 pm
Sale		13GSyros Pharmaceuticals Inc.
SYRS		ARCH Venture Fund VII L.P.0
0.000%		-3,341,770decrease
(Position Closed)		View
2020-02-14
12:26 pm
Purchase		13GTwist Bioscience Corp
TWST		ARCH Venture Fund VII L.P.3,367,158
10.200%		5,590increase
(+0.17%)		View
2020-02-13
4:51 pm
Purchase		13GUnity Biotechnology Inc.
UBX		ARCH Venture Fund VII L.P.10,061,740
21.900%		13,559increase
(+0.13%)		View
2020-02-13
4:50 pm
Sale		13GSyros Pharmaceuticals Inc.
SYRS		ARCH Venture Fund VII L.P.3,341,770
7.900%		-1,295,367decrease
(-27.93%)		View